跳至主要内容
临床试验/2024-519728-26-00
2024-519728-26-00招募中4 期

Frozen shoulder – the role of physiotherapy

Oslo University Hospital HF1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2025年6月4日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
180
试验地点
1
主要终点
Shoulder Pain and Disability Index

研究概览

简要总结

There is a need for high-quality studies evaluating the effectiveness of physiotherapy combined with intra-articular corticosteroid injections for improving shoulder function in patients with frozen shoulder. We aim to compare the effectiveness of physical therapy, corticosteroid injections, and their combination, on pain and function at 3 months in patients with frozen shoulder.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Shoulder pain <9 months
  • Reduced passive range of movement in the glenohumeral joint compared with the unaffected side, more than 30 degrees for at least two of these three movements: forward flexion, abduction or external rotation.
  • Shoulder pain intensity >3 on a scale from 0 (no pain) to 10 (worst possible pain) in either activity or rest (including night)
  • Age 18 to 70 years
  • Capable of giving signed informed consent as described in Appendix 1 which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.

排除标准

  • 1.Shoulder joint osteoarthritis
  • Bleeding disorders
  • Active cancer or infectious disease 4.Serious psychiatric or neurological disorder
  • Using corticosteroid tablets for other medical conditions
  • Prior corticosteroid injection for frozen shoulder in the affected shoulder

结局指标

主要结局

Shoulder Pain and Disability Index

Shoulder Pain and Disability Index

次要结局

  • Pain intensity rest and activity, Quick-DASH, EQ-5D-5L, Hopkins Symptom Checklist-10, Tampa Scale of Kinesiophobia, iMTA Medical Consumption Questionnaire, iMTA Productivity Cost Questionnaire, Patient Accepted Symptom State, Global Rating of Change scale

研究者

发起方
Oslo University Hospital HF
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

John Bjørneboe

Scientific

Oslo University Hospital HF

研究点 (1)

Loading locations...

相似试验